Vascular Biogenics - 48 Year Dividend History | VBLT
Historical dividend payout and yield for Vascular Biogenics (VBLT) since 1971. The current TTM dividend payout for Vascular Biogenics (VBLT) as of June 14, 2019 is $0.00. The current dividend yield for Vascular Biogenics as of June 14, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Vascular Biogenics Ltd. is a clinical stage biotechnology company. It is focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer. It is also developing VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. Vascular Biogenics Ltd. is headquartered in Or Yehuda, Israel.